Coeptis Therapeutics Inc. — Form D/A
Coeptis Therapeutics Inc. of WEXFORD, PA, a company, filed a Form D amendment with the SEC on 2021-10-12. The offering totals $9.0M, of which $5.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-10-12
- Form: D/A
- Accession: 0001683168-21-004774
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.0M
- Amount sold: $5.5M
- Remaining: $3.5M
- Investors: 42
- Date of first sale: 2021-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-393300
Issuer
- Name: Coeptis Therapeutics Inc.
- CIK: 0001819663
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 105 BRADFORD RD, SUITE 420, WEXFORD, PA, 15090
- Phone: 724-934-6467
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Michael Handley | Director | Fremont, CA |
| David Mehalick | Director | Naples, FL |
| Christine Sheehy | Director | Wexford, PA |
| Daniel Yerace | Director | Wexford, PA |
| David Mehalick | Executive Officer | Naples, FL |
| Christine Sheehy | Executive Officer | Wexford, PA |
| Daniel Yerace | Executive Officer | Wexford, PA |
Other filings by this issuer (3)
More